CareCloud (NASDAQ:CCLD – Free Report) had its target price raised by Benchmark from $4.00 to $4.50 in a research report report published on Tuesday morning, Benzinga reports. Benchmark currently has a buy rating on the stock.
CareCloud Stock Down 2.2 %
CareCloud stock opened at $2.70 on Tuesday. The company has a 50 day moving average of $2.23 and a 200-day moving average of $1.87. The company has a quick ratio of 1.00, a current ratio of 1.02 and a debt-to-equity ratio of 0.22. CareCloud has a twelve month low of $0.68 and a twelve month high of $3.80. The stock has a market capitalization of $43.59 million, a PE ratio of -0.71 and a beta of 1.33.
Hedge Funds Weigh In On CareCloud
A hedge fund recently raised its stake in CareCloud stock. Renaissance Technologies LLC increased its position in shares of CareCloud, Inc. (NASDAQ:CCLD – Free Report) by 25.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 107,200 shares of the company’s stock after buying an additional 21,500 shares during the quarter. Renaissance Technologies LLC owned 0.66% of CareCloud worth $206,000 as of its most recent SEC filing. 10.16% of the stock is owned by institutional investors and hedge funds.
About CareCloud
CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.
Featured Stories
- Five stocks we like better than CareCloud
- Transportation Stocks Investing
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- Profitably Trade Stocks at 52-Week Highs
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- Stock Analyst Ratings and Canadian Analyst Ratings
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for CareCloud Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareCloud and related companies with MarketBeat.com's FREE daily email newsletter.